Chung et al evaluated Chinese patients with Sjogren’s Syndrome for the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). The authors are from China Medical University, Central Taiwan University of Science and Technology, and Taichung Hospital in Taiwan.
Patient selection: Chinese adult with Sjogren’s Syndrome
Risk factors for DVT and/or PE (comorbidities):
(1) atrial fibrillation
(2) diabetes mellitus
(3) history of cerebrovascular accident
(4) heart failure
(5) lower leg fracture or surgery
(6) cancer
(7) pregnancy
Sjogren’s |
Comorbidity |
HR DVT |
HR PE |
No |
0 |
1 |
1 |
Yes |
0 |
1.5 |
4.1 |
No |
>= 1 |
1.7 |
3.6 |
Yes |
>= 1 |
3.7 |
11.4 |
where:
• A patient with atrial fibrillation or lower leg surgery may be receiving anticoagulation therapy, which would lower the risk for DVT or PE.
• While some comorbid conditions would be lifelong, pregnancy and lower leg trauma would be transient risk factors.
A person with secondary Sjogren’s syndrome (associated with RA, SLE, PBC, or scleroderma) has a greater risk than a patient with primary Sjogren’s syndrome.
Sjogren Status |
HR DVT |
HR PE |
none |
1 |
1 |
primary |
1.8 |
3.2 |
secondary |
3.3 |
5.1 |
While the hazard ratios look significant, the cumulative incidence of DVT or PE in a patient with Sjogren’s syndrome over 10 years is 0.7% (Figure 1).
Specialty: Hematology Oncology, Clinical Laboratory
ICD-10: ,